tetano
Editor, Senior Moderator
Vaccine. 2018 Feb 14. pii: S0264-410X(18)30200-7. doi: 10.1016/j.vaccine.2018.02.026. [Epub ahead of print]
[h=1]Intradermal immunization with inactivated swine influenza virus and adjuvant polydi(sodium carboxylatoethylphenoxy)phosphazene (PCEP) induced humoral and cell-mediated immunity and reduced lung viral titres in pigs.[/h] Magiri R[SUP]1[/SUP], Lai K[SUP]2[/SUP], Chaffey A[SUP]1[/SUP], Zhou Y[SUP]2[/SUP], Pyo HM[SUP]2[/SUP], Gerdts V[SUP]2[/SUP], Wilson HL[SUP]3[/SUP], Mutwiri G[SUP]1[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] Swine influenza virus is endemic worldwide and it is responsible for significant economic losses to the swine industry. A vaccine that stimulates a rapid and long-lasting protective immune response to prevent this infection is highly sought. Poly[di(sodium carboxylatoethylphenoxy)-phosphazene (PCEP) has demonstrated adjuvant activity when formulated as part of multiple vaccines in mice and pigs. In this study we examined the magnitude and type of immune response induced in pigs vaccinated via the intramuscular or intradermal routes with inactivated swine influenza virus (SIV) H1N1 vaccine formulated with PCEP. Intradermal administration of PCEP-adjuvanted inactivated SIV vaccine stimulated significant anti-SIV antibody titres, increased neutralizing antibodies, and significantly reduced lung virus load with limited reduction of gross lung lesions after challenge with virulent H1N1 relative to control animals. These results indicate that PCEP may be effective as a vaccine adjuvant against swine influenza viruses in pigs and should be considered a potential candidate adjuvant for future swine intradermal influenza vaccines.
[h=4]KEYWORDS:[/h] Influenza; Neutralizing antibodies; Protection; Route; Swine; Vaccine
PMID: 29454517 DOI: 10.1016/j.vaccine.2018.02.026
[h=1]Intradermal immunization with inactivated swine influenza virus and adjuvant polydi(sodium carboxylatoethylphenoxy)phosphazene (PCEP) induced humoral and cell-mediated immunity and reduced lung viral titres in pigs.[/h] Magiri R[SUP]1[/SUP], Lai K[SUP]2[/SUP], Chaffey A[SUP]1[/SUP], Zhou Y[SUP]2[/SUP], Pyo HM[SUP]2[/SUP], Gerdts V[SUP]2[/SUP], Wilson HL[SUP]3[/SUP], Mutwiri G[SUP]1[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] Swine influenza virus is endemic worldwide and it is responsible for significant economic losses to the swine industry. A vaccine that stimulates a rapid and long-lasting protective immune response to prevent this infection is highly sought. Poly[di(sodium carboxylatoethylphenoxy)-phosphazene (PCEP) has demonstrated adjuvant activity when formulated as part of multiple vaccines in mice and pigs. In this study we examined the magnitude and type of immune response induced in pigs vaccinated via the intramuscular or intradermal routes with inactivated swine influenza virus (SIV) H1N1 vaccine formulated with PCEP. Intradermal administration of PCEP-adjuvanted inactivated SIV vaccine stimulated significant anti-SIV antibody titres, increased neutralizing antibodies, and significantly reduced lung virus load with limited reduction of gross lung lesions after challenge with virulent H1N1 relative to control animals. These results indicate that PCEP may be effective as a vaccine adjuvant against swine influenza viruses in pigs and should be considered a potential candidate adjuvant for future swine intradermal influenza vaccines.
[h=4]KEYWORDS:[/h] Influenza; Neutralizing antibodies; Protection; Route; Swine; Vaccine
PMID: 29454517 DOI: 10.1016/j.vaccine.2018.02.026